Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1514 of 5804
-
New device aims to ease bathroom troubles for men with enlarged prostate
Symptom relief OngoingA prospective, multicenter, blind randomized (2:1) controlled study comparing the International Prostate Symptom Score (IPSS) of the Active arm to the IPSS of the control arm at the 3 months follow-up and active arm IPSS score change from time zero to 12 months. Patients in the a…
Phase: NA • Sponsor: Butterfly Medical Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Could setanaxib boost keytruda against head and neck cancer?
Disease control CompletedThe primary objective of this study is to compare the change in tumour size per Response Evaluation Criteria in Solid Tumours Version 1.1 (RECIST v1.1) in recurrent or metastatic SCCHN patients treated with setanaxib and pembrolizumab versus patients treated with placebo and pemb…
Phase: PHASE2 • Sponsor: Calliditas Therapeutics Suisse SA • Aim: Disease control
Last updated Jun 26, 2026 13:14 UTC
-
New valve implant offers hope for rare heart condition
Disease control OngoingThe purpose of this investigation is to see if the TRICENTO Valved Stent Graft implant reduces tricuspid regurgitation (TR) and improves the symptoms and quality of life in 15 participants with carcinoid heart disease, and who are not able to have a new valve via a surgical proce…
Phase: NA • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Could a few days of radiation replace weeks for sarcoma patients?
Disease control TerminatedThis research study is designed to find out if radiation therapy treatment prior to surgery is safe and effective to treat soft tissue sarcomas. 30 participants with soft tissue sarcoma will be enrolled and can expect to be on study for up to 5 years.
Phase: PHASE2 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Could a gentle brain zap ease PTSD symptoms? new study investigates
Knowledge-focused Recruiting nowThis study will take a basic neuroscience approach to investigate pathological mechanisms underlying PTSD. Additionally, the study aims to identify how Transcranial Alternating Current Stimulation (tACS) brain stimulation can modulate and correct neural networks and related emoti…
Phase: NA • Sponsor: The University of Texas Health Science Center, Houston • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:42 UTC
-
Can stem cells save sight? new trial tests eye cell transplant for dry AMD
Disease control Recruiting nowThe main objective of the study is evaluation of the safety and tolerability of RPESC-RPE-4W as therapy for dry AMD.
Phase: PHASE1, PHASE2 • Sponsor: Luxa Biotechnology, LLC • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New drug shows promise for slowing kidney disease in IgA nephropathy patients
Disease control ENROLLING_BY_INVITATIONTo evaluate the long-term safety and tolerability of sibeprenlimab in subjects with IgAN
Phase: PHASE2, PHASE3 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Experimental combo targets leukemia by starving cancer cells
Disease control OngoingPegylated arginine deiminase (ADI-PEG 20) will be combined with venetoclax and azacitidine for treatment of subjects with previously treated or untreated with high risk factor acute myeloid leukemia (AML). Venetoclax and azacitidine are front-line therapy for such patients, and A…
Phase: PHASE1 • Sponsor: Polaris Group • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Pea power: Plant-Based drink may cut feeding tube need in cancer patients
Disease control OngoingThis phase II trial studies the effect of a plant-based oral nutrition supplement, Kate Farms Standard 1.4 and/or Standard 1.0. as a primary source of nutrition in reducing the gastrostomy tube placement rate in patients with head and neck cancer that has spread to nearby tissue …
Phase: NA • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Can a radioactive injection target bone tumors? a Dose-Finding trial aims to find out
Disease control TerminatedTo determine the Maximum Tolerated Dose (MTD) of CycloSam®, Samarium-153-DOTMP (Sm-153-DOTMP), a radiopharmaceutical that delivers radiation to the bone when injected, given as a tandemly administered pair of doses to subjects with one or more solid tumor(s) in the bone or metast…
Phase: PHASE1 • Sponsor: QSAM Therapeutics, Inc. • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can a 45-Minute class help teens quit tobacco?
Prevention CompletedTobacco use is increasing among youth in the U.S. However evidence for the long-term effectiveness of tobacco cessation programs for youth is limited. The current study seeks to adapt and evaluate a universal group-based youth brief tobacco intervention for 9th grade students. T…
Phase: NA • Sponsor: University of Virginia • Aim: Prevention
Last updated Jun 27, 2026 12:09 UTC
-
Simple dialysis tweak could save thousands of lives
Disease control OngoingMany patients on hemodialysis have low levels of magnesium. Magnesium is needed to keep the heart, kidneys, and other organs working properly. Patients with low serum magnesium concentration have a higher risk of death, heart issues, muscle cramps and fractures. There are several…
Phase: NA • Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Can outreach programs close the kidney transplant racial gap?
Knowledge-focused CompletedThis project will study how kidney care for everyone despite race can reduce racial differences in care and improve access to kidney transplants, and specifically living donor kidney transplants (LDKT), for individuals with chronic kidney disease. A study focused on equality and …
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
New hope for chemo patients: drug may shield nerves from painful side effect
Symptom relief CompletedOxaliplatin is effective in adjuvant and first-line colorectal cancer chemotherapy. Oxaliplatin-induced severe chronic neurotoxicity is the main dose-limiting adverse event. No standard treatment for oxaliplatin-induced chronic toxicity has been defined. Neurotropin has been iden…
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
Smart bike could help Parkinson's patients exercise from home
Symptom relief CompletedThis research will develop novel and accessible way to deliver effective and customized rehab to those suffering from common and devastating neurodegenerative condition called Parkinson's disease. The investigators will examine the efficacy of novel rehab technique that can be mo…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
Keyhole surgery vs. open chest: which is better for osteosarcoma lung spread?
Disease control Recruiting nowThis phase III trial compares the effect of open thoracic surgery (thoracotomy) to thoracoscopic surgery (video-assisted thoracoscopic surgery or VATS) in treating patients with osteosarcoma that has spread to the lung (pulmonary metastases). Open thoracic surgery is a type of su…
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Heart attack diagnosis gets a Sex-Specific upgrade: new study could save Women's lives
Diagnosis CompletedAcute myocardial infarction (MI) is defined as a rise and/or fall in cardiac troponins (cTn) with at least one value above the 99th percentile upper reference limit (URL) in the context of symptoms or clinical evidence of myocardial ischemia. The URL is based on measurements in a…
Phase: NA • Sponsor: Herlev Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:33 UTC
-
New therapy targets sleep and daily rhythms to fight teen suicide
Symptom relief CompletedThe purpose of this study is to advance a non-pharmacologic suicide preventive intervention with wide dissemination potential as an innovative high-yield solution to reduce suicide rates. The investigators aim to achieve this with this study of Brain Emotion Circuitry Self-Monito…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
New MRI technique could catch osteoarthritis years earlier
Diagnosis Recruiting nowCurrently the diagnosis of OA is based on radiographs and clinical findings, which is limited to detecting late-stage disease. There is a pressing, unmet clinical need for robust assessment of early changes in cartilage health. Towards this goal, extensive efforts are ongoing to …
Sponsor: Xiaojuan Li • Aim: Diagnosis
Last updated Jun 27, 2026 09:08 UTC
-
Electric fields plus chemo: new hope for tough pancreatic cancer?
Disease control Recruiting nowThis is a Phase I/Ib trial, single-center, non-randomized, open-label study of Protein-bound Paclitaxel, Cisplatin, And Gemcitabine (GCN) Combined with Tumor Treatment Fields (TTF) and G+TTF maintenance therapy in patients with metastatic pancreatic cancer.
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC